David F. Hale's most recent trade in Dermata Therapeutics Inc was a trade of 2,500 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Jan. 2, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Dermata Therapeutics Inc | Mr. David F. Hale | Director | 02 Jan 2026 | 2,500 | 2,500 | - | - | Stock Option (Right to Buy) | ||
| Dermata Therapeutics Inc | Mr. David F. Hale | Director | 21 Jan 2025 | 78,741 | 78,741 | - | - | Warrant (Right to Buy) | ||
| Dermata Therapeutics Inc | Mr. David F. Hale | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jan 2025 | 78,741 | 80,957 | - | - | Common Stock | |
| Dermata Therapeutics Inc | Mr. David F. Hale | Director | 13 Jan 2025 | 5,000 | 5,000 | - | - | Stock Option (Right to Buy) | ||
| Oncternal Therapeutics Inc | David F. Hale | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2024 | 3,300 | 3,300 | - | - | Stock Options | |
| Oncternal Therapeutics Inc | David Hale F. | Director | Purchase of securities on an exchange or from another person at price $ 9.04 per share. | 23 Feb 2024 | 714 | 714 (0%) | 0% | 9.0 | 6,455 | Common Stock |
| Oncternal Therapeutics Inc | David F. Hale | Director | Purchase of securities on an exchange or from another person at price $ 9.04 per share. | 23 Feb 2024 | 266 | 29,673 (0%) | 0% | 9.0 | 2,405 | Common Stock |
| Dermata Therapeutics Inc | Mr. David F. Hale | Director | 04 Jan 2024 | 10,000 | 10,000 | - | - | Stock Option (Right to Buy) | ||
| Oncternal Therapeutics Inc | David F. Hale | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jun 2023 | 37,500 | 37,500 | - | - | Stock Options | |
| Dermata Therapeutics Inc | Mr. David F. Hale | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Oct 2022 | 30,155 | 75,720 | - | 0 | - | |
| Dermata Therapeutics Inc | Mr. David F. Hale | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Oct 2022 | 30,155 | 75,720 | - | 0 | - | |
| Dermata Therapeutics Inc | Mr. David F. Hale | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jul 2022 | 26,441 | 45,565 | - | 0 | Common Stock | |
| Oncternal Therapeutics Inc | David F. Hale | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2022 | 37,500 | 37,500 | - | - | Stock Options | |
| Dermata Therapeutics Inc | Mr. David F. Hale | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Apr 2022 | 15,466 | 19,124 | - | 0 | Common Stock | |
| Dermata Therapeutics Inc | Mr. David F. Hale | Director | 03 Jan 2022 | 5,000 | 5,000 | - | - | Stock Option (right to buy) |